Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. (Q40100311)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. |
scientific article |
Statements
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells (English)
Napoleone Ferrara
Farbod Shojaei
Xiumin Wu
Cuiling Zhong
Megan E Baldwin
Stefanie Schanz
Germaine Fuh
Hans-Peter Gerber